Realistic illustration of UCLA Health study linking residential chlorpyrifos exposure to heightened Parkinson's risk, featuring pesticide spraying near homes, Parkinson's symptoms, brain neuron damage, and lab research.
Realistic illustration of UCLA Health study linking residential chlorpyrifos exposure to heightened Parkinson's risk, featuring pesticide spraying near homes, Parkinson's symptoms, brain neuron damage, and lab research.
AI에 의해 생성된 이미지

UCLA Health study links long-term chlorpyrifos exposure to higher Parkinson’s risk

AI에 의해 생성된 이미지
사실 확인됨

A UCLA Health study reports that people with long-term residential exposure to the pesticide chlorpyrifos had more than a 2.5-fold higher likelihood of developing Parkinson’s disease. The research, published in Molecular Neurodegeneration, pairs human exposure estimates with animal and zebrafish experiments that found dopamine-neuron damage and disruptions to the brain’s protein “cleanup” system.

Researchers at UCLA Health examined data from 829 people diagnosed with Parkinson’s disease and 824 people without the condition, all participants in UCLA’s Parkinson’s Environment and Genes study.

To estimate exposure, the team combined California pesticide-use records with participants’ residential and workplace location histories to reconstruct likely chlorpyrifos exposure patterns over many years.

The analysis found that individuals with long-term residential exposure to chlorpyrifos had more than a 2.5 times greater risk of developing Parkinson’s disease than those with little or no exposure.

Chlorpyrifos has been widely used in agriculture for decades. Its residential use was banned in 2001, and restrictions on agricultural applications were introduced in 2021. Despite those limits, UCLA said the chemical continues to be used on a variety of crops in the United States and remains common in other parts of the world.

The researchers also conducted laboratory tests to probe potential biological mechanisms. In one set of experiments, mice inhaled aerosolized chlorpyrifos for 11 weeks, using an exposure approach the researchers said was designed to mimic how people typically encounter the chemical. The mice developed movement problems and lost dopamine-producing neurons, and researchers observed brain inflammation and an abnormal buildup of alpha-synuclein, a protein that forms clumps in the brains of people with Parkinson’s.

In zebrafish experiments, the researchers found that chlorpyrifos disrupted autophagy, the cellular process that clears damaged proteins. When the team restored this process—or removed synuclein protein—the neurons were protected from injury.

“\"This study establishes chlorpyrifos as a specific environmental risk factor for Parkinson's disease, not just pesticides as a general class,\"” said Dr. Jeff Bronstein, a professor of neurology at UCLA Health and the study’s senior author. “\"By showing the biological mechanism in animal models, we've demonstrated that this association is likely causal. The discovery that autophagy dysfunction drives the neurotoxicity also points us toward potential therapeutic strategies to protect vulnerable brain cells.\"”

Parkinson’s is a progressive neurological disorder that can cause tremors, muscle stiffness and increasing difficulty with movement. UCLA noted that nearly one million people in the United States are living with the condition.

The researchers said identifying specific chemicals associated with higher Parkinson’s risk could help guide prevention efforts and might help identify individuals who could benefit from earlier neurological monitoring or future protective therapies. They also said future research may examine whether other commonly used pesticides affect the brain in similar ways.

사람들이 말하는 것

Initial reactions on X to the UCLA Health study linking long-term chlorpyrifos exposure to a 2.5-fold higher Parkinson's risk are limited and neutral, primarily consisting of shares summarizing the key findings from human exposure data and animal experiments.

관련 기사

Realistic illustration of a pregnant woman and child in NYC, symbolizing study on prenatal chlorpyrifos exposure linked to brain abnormalities and motor skill issues in children.
AI에 의해 생성된 이미지

Study links prenatal chlorpyrifos exposure to widespread, lasting brain abnormalities in children

AI에 의해 보고됨 AI에 의해 생성된 이미지 사실 확인됨

A peer‑reviewed study of New York City children reports that higher prenatal exposure to the insecticide chlorpyrifos is associated with widespread differences in brain structure, function, and metabolism—and with poorer motor skills—that persist into adolescence.

Researchers are shifting focus from genetics to environmental toxins in water as a potential cause of Parkinson's disease. The story of former Navy officer Amy Lindberg illustrates how symptoms can emerge unexpectedly in retirement. Her experience highlights the disease's impact on active lives near coastal areas.

AI에 의해 보고됨 사실 확인됨

Researchers at Case Western Reserve University report they have identified an abnormal interaction between the Parkinson’s-linked protein alpha-synuclein and the enzyme ClpP that disrupts mitochondrial function in experimental models. They also describe an experimental compound, CS2, designed to block that interaction, which they say improved movement and cognitive performance and reduced brain inflammation in lab and mouse studies.

Keck Medicine of USC researchers are testing an experimental approach to Parkinson’s disease that implants lab-grown, dopamine-producing cells into a movement-control region of the brain. The early-stage Phase 1 REPLACE trial involves up to 12 people with moderate to moderate-severe Parkinson’s disease, and the U.S. Food and Drug Administration has granted the study fast-track designation.

AI에 의해 보고됨 사실 확인됨

Doctors at Keck Medicine of USC are implanting lab-grown, dopamine-producing cells into the brains of people with Parkinson’s disease in an early-stage clinical trial that will enroll up to 12 participants across three U.S. sites.

Researchers at Brazil’s Federal University of ABC report a simple copper-chelating molecule that reduced beta-amyloid–linked pathology and improved memory in rats. The compound showed no detectable toxicity in preclinical tests and, based on computer modeling, is predicted to cross the blood–brain barrier. The team is seeking industry partners for clinical development.

AI에 의해 보고됨

Researchers have discovered that Chlamydia pneumoniae, a bacterium commonly causing pneumonia and sinus infections, may contribute to Alzheimer's disease by invading the retina and brain. The study found higher levels of the bacterium in Alzheimer's patients, particularly those with the APOE4 gene variant, associated with greater cognitive decline. This suggests potential new treatment avenues targeting infection and inflammation.

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부